Must read for anyone new to TNXP - There are obviously a lot of new people entering this stock so I want to clear some things up. Many of us have been in TNXP since late 2013 when Joe Springer initially exposed its potential. It went from the $6 range to $10 to $21 very quickly. At the time I believe the stock got a little ahead of itself. It think it's because it went from no exposure to on the radar. Many of us rode the wave back down to reality until TNXPs Phase 2 trials primary endpoint was not met. That's when the stock dropped from the $14 range to under $6. Many people left the stock and the exposure went back to near zero.
The TNXP team reviewed data with the FDA and they decided that one of their secondary endpoints in the Phase 2 was acceptable (this secondary measure was also what other FDA approved drugs in the past have used as their primary endpoint). After that meeting they had a high performing Phase 2 trial but the stock did not recover because most people wrote it off as a loss. There was no one to drive the price back to its old levels.
Since then, many of us have patiently waited until this stock was discovered again. Oppenheimer didn't want to go out on limb until the full Phase 2 report was released. The long term data looked great and they recently suggested a price target of $18 and a BUY rating. At the same time JBem, who has any followers, exposed the stock to many people. This is what we had been waiting for.
Everyone who had been in the stock since the large drop from $14 to $6 knows that this stock is worth much more than it was back then. The stock is returning to its past market value and will continue to rise from here. This is not a pump and dump like many of the new followers believe.
The team consist of Dr. Saks who was the former CEO of Jazz Pharmaceutical (Check out ticker JAZZ) and Dr. Mario who was the Chief Executive of Glaxo, the second largest drug company in the world, among many other very successful members. These guys know what they are doing and know how to bring a product to market.
Buy TNXP and hold for the long run. We're on the ground floor of something extraordinary. Special thanks to Springer, Napodano, JBem, Joanne and many more.
